Anti-SLC17A4 monoclonal antibody

Pre-made anti-SLC17A4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC17A4/SLC17A4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1653-Ab-1/ GM-Tg-hg-IP1653-Ab-2Anti-Human SLC17A4 monoclonal antibodyHuman
GM-Tg-rg-IP1653-Ab-1/ GM-Tg-rg-IP1653-Ab-2Anti-Rat SLC17A4 monoclonal antibodyRat
GM-Tg-mg-IP1653-Ab-1/ GM-Tg-mg-IP1653-Ab-2Anti-Mouse SLC17A4 monoclonal antibodyMouse
GM-Tg-cynog-IP1653-Ab-1/ GM-Tg-cynog-IP1653-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC17A4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1653-Ab-1/ GM-Tg-felg-IP1653-Ab-2Anti-Feline SLC17A4 monoclonal antibodyFeline
GM-Tg-cang-IP1653-Ab-1/ GM-Tg-cang-IP1653-Ab-2Anti-Canine SLC17A4 monoclonal antibodyCanine
GM-Tg-bovg-IP1653-Ab-1/ GM-Tg-bovg-IP1653-Ab-2Anti-Bovine SLC17A4 monoclonal antibodyBovine
GM-Tg-equg-IP1653-Ab-1/ GM-Tg-equg-IP1653-Ab-2Anti-Equine SLC17A4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1653-Ab-1/ GM-Tg-hg-IP1653-Ab-2; GM-Tg-rg-IP1653-Ab-1/ GM-Tg-rg-IP1653-Ab-2;
GM-Tg-mg-IP1653-Ab-1/ GM-Tg-mg-IP1653-Ab-2; GM-Tg-cynog-IP1653-Ab-1/ GM-Tg-cynog-IP1653-Ab-2;
GM-Tg-felg-IP1653-Ab-1/ GM-Tg-felg-IP1653-Ab-2; GM-Tg-cang-IP1653-Ab-1/ GM-Tg-cang-IP1653-Ab-2;
GM-Tg-bovg-IP1653-Ab-1/ GM-Tg-bovg-IP1653-Ab-2; GM-Tg-equg-IP1653-Ab-1/ GM-Tg-equg-IP1653-Ab-2
Products NameAnti-SLC17A4 monoclonal antibody
Formatmab
Target NameSLC17A4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC17A4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1653-Ag-1Recombinant multi-species S17A4/ SLC17A4/ KAIA2138 protein


    Target information

    Target IDGM-IP1653
    Target NameSLC17A4
    Gene ID10050,319848,679784,694213,100688596,101085718,512725,100052756
    Gene Symbol and Synonyms9130214H05Rik,KAIA2138,SLC17A4
    Uniprot AccessionQ9Y2C5
    Uniprot Entry NameS17A4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000146039
    Target ClassificationN/A

    The target: SLC17A4, gene name: SLC17A4, also named as KAIA2138. Phosphate homeostasis is maintained by regulating intake, intestinal absorption, bone deposition and resorption, and renal excretion of phosphate. The central molecule in the control of phosphate excretion from the kidney is the sodium/phosphate cotransporter NPT1 (SLC17A1; MIM 182308), which is located in the renal proximal tubule. NPT1 uses the transmembrane electrochemical potential gradient of sodium to transport phosphate across the cell membrane. SLC17A4 is a similar sodium/phosphate cotransporter in the intestinal mucosa that plays an important role in the absorption of phosphate from the intestine (summary by Shibui et al., 1999 [PubMed 10319585]).[supplied by OMIM, Feb 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.